UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | D | E | G | M | N | S | T
Number of items: 15.

A

Agnelli, G; Gallus, A; Goldhaber, S; Haas, S; Huisman, MV; Hull, R; ... Misselwitz, F; + view all (2006) Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study. In: EUROPEAN HEART JOURNAL. (pp. 761 - 762). OXFORD UNIV PRESS

D

Dotsenko, O; Kakkar, AK; (2006) Thrombosis and cancer. ANNALS OF ONCOLOGY , 17 X81 - X84. 10.1093/annonc/mdl242.

E

Eriksson, BI; Borris, L; Dahl, OE; Haas, S; Huisman, MV; Kakkar, AK; ... Odixa-Hip Study Investigators,; + view all (2006) Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J THROMB HAEMOST , 4 (1) 121 - 128.

Eriksson, BI; Borris, LC; Dahl, OE; Haas, S; Huisman, MV; Kakkar, AK; ... ODIXa-HIP Study Invest,; + view all (2006) A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. CIRCULATION , 114 (22) 2374 - 2381.

G

Gooding, KM; Hannemann, MM; Tooke, JE; Clough, GF; Shore, AC; (2006) Maximum skin hyperaemia induced by local heating: Possible mechanisms. J VASC RES , 43 (3) 270 - 277. 10.1159/000091736.

Gooding, KM; Whatmore, JL; Tullett, J; Middlebrooke, AR; Demaine, A; Jarvis, D; ... Shore, AC; + view all (2006) The impact of polymorphisms in the promoter region of the aldose reductase gene on microvascular function in healthy subjects. In: JOURNAL OF VASCULAR RESEARCH. (pp. 59 - 59). KARGER

Gooding, KM; Whatmore, JL; Tullett, J; Middlebrooke, AR; Demaine, AG; Tooke, JE; Shore, AC; (2006) Microvascular function is altered by polymorphisms in the promoter region of the aldose reductase gene in healthy subjects. In: HYPERTENSION. (pp. 774 - 774). LIPPINCOTT WILLIAMS & WILKINS

Gorshunska, MY; Gooding, KM; Mawson, DM; Ball, CI; Piper, J; Tooke, JE; Shore, AC; (2006) Microvascular distensibility in Type 2 diabetic patients: Relationship to hypertension and insulin resistance. In: JOURNAL OF VASCULAR RESEARCH. (pp. 29 - 29). KARGER

M

Middlebrooke, AR; Elston, LM; MacLeod, KM; Mawson, DM; Ball, CI; Shore, AC; Tooke, JE; (2006) Six months of aerobic exercise does not improve microvascular function in type 2 diabetes mellitus. DIABETOLOGIA , 49 (10) 2263 - 2271. 10.1007/s00125-006-0361-x.

Mueck, W; Eriksson, BI; Borris, LC; Dahl, OE; Haas, S; Huisman, MV; ... Misselwitz, F; + view all (2006) Rivaroxaban for thromboprophylaxis in patients undergoing total hip replacement: Comparison of pharmacokinetics and pharmacodynamics with once- and twice-daily dosing. In: BLOOD. (pp. 271A - 271A). AMER SOC HEMATOLOGY

N

Nicolaides, AN; Fareed, J; Kakkar, AK; Breddin, HK; Goldhaber, SZ; Hull, R; ... Kalodiki, E; + view all (2006) Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence). INT ANGIOL , 25 (2) 101 - 161.

S

Shore, AC; Fulford, J; Sriraman, R; Ball, CI; Armstrong, N; Tooke, JE; (2006) Mitochondrial function and skeletal muscle perfusion in healthy and type 2 diabetic subjects. In: HYPERTENSION. (pp. 780 - 780). LIPPINCOTT WILLIAMS & WILKINS

Shore, AC; Sriraman, R; Ball, CI; Fulford, J; Armstrong, N; Tooke, JE; (2006) Skeletal muscle perfusion and mitochondrial function in healthy and type 2 diabetic subjects. In: JOURNAL OF VASCULAR RESEARCH. (pp. 31 - 31). KARGER

Singh, A; Satchell, SC; Neal, CR; Tooke, JE; Mathieson, PW; (2006) The human glomerular endothelial glycocalyx: Characterisation and barrier properties. In: NEPHROLOGY DIALYSIS TRANSPLANTATION. (pp. 312 - 312). OXFORD UNIV PRESS

T

Tooke, JE; Elston, LM; Gooding, KM; Ball, CI; Mawson, DM; Piper, J; ... Shore, AC; + view all (2006) The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin. DIABETOLOGIA , 49 (5) 1064 - 1070. 10.1007/s00125-006-0168-9.

This list was generated on Sun Sep 21 01:32:53 2014 BST.